Q1 2024 Revenue: $3.1 million, down from $4.1 million in Q1 2023. 2024 Revenue Forecast: Expected to be between $16 million to $18 million. Net Loss: $20.7 million for Q1 2024, improved from $24 ...

The seer of Chitradurga's Sri Murugha Mutt, Shivamurthy Murugha Sharanaru, accused of raping minor girls staying in the mutt, ...

Seer, Inc. will announce Q1 2025 financial results on May 13, 2025, with a live webcast at 1:30 PM PT. Seer, Inc., a life sciences company specializing in proteomics, announced that it will release ...

Seer Inc (NASDAQ:SEER) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is $3.75 million, and the earnings are expected to come in at -$0.37 per share.

Revenue: $4.2 million for Q1 2025, a 37% increase from $3.1 million in Q1 2024. Product Revenue: $2.9 million, including $5,000 from related parties. Service Revenue: $1.2 million, including $47,000 ...

Many Seer, Inc. (NASDAQ:SEER) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders are buying is usually more helpful when ...

REDWOOD CITY, Calif. - Seer, Inc. (NASDAQ: SEER), a life sciences company known for its Proteograph Product Suite, has announced findings from studies that reveal changes in the human plasma proteome ...

Radiotherapy for breast cancer reduces disease recurrence and breast cancer mortality. However, it has also been associated with increased second cancer risks in exposed sites. We evaluated long-term ...